Gitnux/Report 2026

Contact Lens Industry Statistics

With global contact lens market forecasts pointing to USD 20.0 billion by 2030 and U.S. contact lens retail sales estimated at USD 1.3 billion in 2023, this page pairs spending and usage trends with the safety and comfort tradeoffs that shape everyday wear. You will also see how daily disposables and silicone hydrogel oxygen performance are linked to lower hypoxia signs while extended and overnight wear raise microbial keratitis risk, plus what FDA reporting and dry eye prevalence suggest about real-world outcomes.
285Statistics
73Sources
12Sections
1Visuals
48mRead
November 11, 2026Updated
Contact Lens Industry Statistics
Elif DemirciWritten by Elif Demirci·Edited by Aisha Okonkwo·Fact-checked by Maya Johansson
Published ·Updated
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 31 days

01 Industry overview

The contact lens industry at a glance

The global contact lens market was valued at $12.0 billion in 2025, with daily-disposable lenses continuing to gain share and North America remaining the largest regional market.

$12.0B[61]
Global market size, 2025
3.9%[61]
Forecast CAGR, 2026–2033
45.2%[61]
North America share, 2025
60%[62]
One-day lens ratio, FY2024
Market size
Grand View Research estimates the global contact lens market at $12.0 billion in 2025 and $12.4 billion in 2026. Menicon's manufacturer shipment-value survey reports a lower but directly observed global total of $10.8 billion for fiscal 2024.[61][62]
Forecast & CAGR
The market is projected to reach $16.2 billion by 2033, implying a 3.9% CAGR from 2026 to 2033. A separate estimate projects growth from $10.60 billion in 2025 to $13.12 billion in 2031 at a 3.62% CAGR, reflecting differences in market scope and methodology.[61][63]
Market share & regions
North America held the largest global revenue share at 45.2% in 2025. In Menicon's fiscal 2024 shipment-value survey, North America accounted for $5.4 billion, Asia for $2.6 billion, and EMEA for $2.8 billion, out of a $10.8 billion total.[61][62]
Segmentation
Daily-disposable lenses represented 60% of the global shipment-value mix in Menicon's fiscal 2024 survey, up from 54% in fiscal 2019. In U.S. 2025 prescribing data, daily disposables led replacement schedules at 43%–59%, ahead of monthly lenses at 28%–35%.[62][37]
Key players & concentration
The market is concentrated among Johnson & Johnson Vision, Alcon, CooperVision, Bausch + Lomb, and Menicon. Alcon's 2024 annual report identifies it as the number-two company in branded contact lenses, while CooperVision reported $2.744 billion in fiscal 2025 revenue.[64][19]
Trends, drivers & challenges
Growth is being supported by conversion from reusable lenses to daily disposables, rising myopia prevalence, specialty myopia-management products, and premium silicone-hydrogel designs. Key challenges include affordability, fitting and compliance requirements, ocular-surface discomfort, and the need for regulatory clearance for new materials and designs.[61][19][65]
Consumer behavior & competition
Daily disposables are the leading replacement modality in U.S. 2025 prescribing data, with a 43%–59% share across the cited data sources, while monthly lenses accounted for 28%–35%. In EMEA's 2024 data, contact-lens penetration ranged from 13.8% of people aged 15–64 in Sweden to 4.5% in Germany, showing substantial country-level variation.[37][38]
M&A
Alcon agreed in August 2025 to acquire STAAR Surgical for $28 per share, valuing the transaction at approximately $1.5 billion; the deal expands Alcon's vision-care portfolio from contact lenses into implantable collamer lenses. ZEISS also announced in June 2025 an agreement to acquire 100% of Brighten Optix, a Taiwanese specialty and orthokeratology lens company.[66][67]
Regulation
In the United States, contact lenses are medical devices and must receive FDA review before marketing; both corrective and decorative lenses require a cleared 510(k) or approved PMA. FDA's device framework includes Class II soft contact-lens care products under 21 CFR 886.5928.[65][33]
Latest news
The latest cited regulatory development is an FDA 510(k) clearance dated February 10, 2026, for the LANDR Contact Lens Case, classified as a Class II soft hydrophilic contact-lens care product. CooperVision also reported fiscal 2025 CooperVision revenue of $2.744 billion, up 5% from fiscal 2024.[33][19]

02 Ranking

Top 10 Companies in the Contact Lens Industry

The leading companies in the contact lens industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 11, 2026 · Next review December 11, 2026

Verdict

HOYA leads Gitnux's 2026 contact lens ranking with an Overall score of 9.6, with revenue growth 9% and operating margin 30.1%. Johnson & Johnson is the runner-up at 9.4, with manufactures more than 1.7 billion ACUVUE lenses annually for U.S. patients.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in contact lens manufacturing

    HOYA

    JP

    Ranked #1 · 9.6 · Contact lens manufacturing

    Why we picked it: It develops and sells contact lenses as part of a global healthcare business, with 30.1% operating margin.

    See in ranking ↓Visit hoya.com ↗

  2. #2 overall

    Johnson & Johnson

    US

    Ranked #2 · 9.4 · Contact lens manufacturing

    Why we picked it: Its ACUVUE line is scaled for U.S. patients at over 1.7 billion lenses per year.

    See in ranking ↓Visit jnj.com ↗

  3. #3 overall

    CooperCompanies

    US

    Ranked #3 · 8.8 · Contact lens manufacturing

    Why we picked it: Its CooperVision segment reported $2.7438 billion in fiscal 2025 net sales across soft and specialty lenses.

    See in ranking ↓Visit coopercos.com ↗

Pick 1 is the #1 company overall. No other segment places in the top 5, so picks 2 and 3 follow rank.

Full ranking

Sort by
Top 10 companies in the contact lens industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

HOYA

Contact lens manufacturing · JP

9.6
2

Johnson & Johnson

Contact lens manufacturing · US

9.4
3

CooperCompanies

Contact lens manufacturing · US

8.8
4

Bausch + Lomb

Contact lens manufacturing · CA

8.3
5

SEED

Contact lens manufacturing · JP

8.3
6

Menicon

Soft, RGP and orthokeratology lenses, global · JP

8.1
7

Mark'ennovy

Custom specialty contact lenses, global · ES

8.0
8

Clearlab

Hydrogel, silicone hydrogel and cosmetic lenses · SG

8.0
9

Euclid Vision Group

Orthokeratology and specialty lenses, global · US

8.0
10

St.Shine Optical

Soft and cosmetic lenses, Taiwan and global OEM · TW

7.0

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 11, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Elif Demirci. (2026, February 13). Top 10 companies in the contact lens industry. In Contact Lens Industry Statistics. Gitnux. https://gitnux.org/contact-lens-industry-statistics/#top-companies

report visual · Projection

Contact lens market shipment value (North America)

Contact lens market shipment value grew from $3.8B in 2019 to $5.4B in 2024.

$3.8B
Start
+7.28%
CAGR · 5y
$5.4B
Projected
20192024
source-verifiedmenicon.com2024

04 Statistics

Technology & Innovation

Technology and innovation coverage includes production scale signals like Taiwan’s projected 288 million lenses per month in 2024 and material adoption at 70% silicone-hydrogel soft fittings in 2024.

AI in the contact lens industry

  • 53.7% of answers from Microsoft Bing were correct in a 2024 study of AI chatbots responding to cornea, conjunctiva, eyelid and contact-lens-related clinical questions.[1]
  • 3 AI chatbots were evaluated for answering common questions about contact-lens wear in a 2024 study.[2]
  • 68.3% of answers from Google Bard were correct in a 2024 study of AI chatbots responding to cornea, conjunctiva, eyelid and contact-lens-related clinical questions.[1]
  • 51.2% of answers from ChatGPT were correct in a 2024 study of AI chatbots responding to cornea, conjunctiva, eyelid and contact-lens-related clinical questions.[1]

Automation in the contact lens industry

  • 288 million contact lenses per month was Taiwan’s projected production capacity in 2024, compared with 32 million in China, according to an industry analysis.[3]
  • 32 million contact lenses per month was China’s projected production capacity in 2024, equal to 11% of Taiwan’s projected capacity.[3]

Digital Transformation in the medical devices sector (sector benchmark)

  • Across medtech and IVD professionals worldwide, 87% said their company had implemented or planned to implement AI or digital solutions in regulatory or quality-management systems in 2020.[4]
  • Across medtech manufacturing executives, 64% highly prioritized digitizing manufacturing in a 2022 survey.[5]
  • Across medtech companies, 29% met or exceeded their digital-transformation targets with sustainable change in 2021, according to BCG’s global survey.[6]
  • Across medtech and IVD professionals worldwide, 89% said their company had implemented or planned to implement AI or digital solutions in its product range in 2020.[4]
  • Across medtech companies, 35% created value but failed to meet all digital-transformation targets in 2021.[6]
  • Across medtech companies, 36% achieved limited value and no sustainable change from digital transformation in 2021.[6]

Technology Adoption in the medical devices sector (sector benchmark)

  • Among emerging medtech companies, 38% had adopted clinical-trial-management systems, compared with 72% of enterprise and global companies in the 2025 benchmark.[7]
  • Across healthcare industrial-ecosystem SMEs in Europe, 17.3% already used robotics in 2023.[8]
  • Across healthcare industrial-ecosystem SMEs in Europe, 31.0% already used cloud technologies in 2023.[8]
  • Across healthcare industrial-ecosystem SMEs in Europe, 8.6% already used remote patient-monitoring technologies in 2023.[8]
  • Among emerging medtech companies, 62% had adopted electronic trial-master-file systems, compared with 89% of enterprise and global companies in the 2025 benchmark.[7]
  • Across healthcare industrial-ecosystem SMEs in Europe, 13.7% already used artificial intelligence in 2023.[8]

Cloud Computing in the medical devices sector (sector benchmark)

  • Across medical-device manufacturing respondents in the global Industry Cloud Study, 21% reported that 75%–100% of infrastructure was in the cloud in 2022.[9]
  • Across medical-device manufacturing respondents in the global Industry Cloud Study, 66% reported that 50%–74% of infrastructure was in the cloud in 2022.[9]
  • Across surveyed medtech organizations, 33% reported reliable enterprise-wide use of cloud-based technologies in 2025.[7]
  • Across surveyed medtech organizations, 31% managed all postmarket-surveillance processes with cloud-based technology in 2025.[7]

Big Data in the medical devices sector (sector benchmark)

  • 80% of medtech companies planned to invest in infrastructure, cloud enablement, tech-architecture modernization, and AI and big data, based on a 2021 global survey.[6]
  • Across medtech companies surveyed by Model N, nearly 70% already used or planned to use data and analytics in 2023.[10]
  • 66.7% of medical device executives identified intelligent data analytics as a major theme for growth opportunities, according to an industry survey cited by Siemens.[11]
  • Across healthcare industrial-ecosystem SMEs in Europe, 15.3% had adopted big data and related data analytics in 2023.[8]
  • 59% of medtech strategy and finance leaders prioritized advanced analytics for revenue management, compared with 57% for GenAI and 32% for AI/ML, in 2025.[10]
  • 15.3% of SMEs in Europe’s healthcare industrial ecosystem had adopted big data and related data analytics, according to the 2023 EMI survey.[8]

IoT in the medical devices sector (sector benchmark)

  • Across healthcare industrial-ecosystem SMEs in Europe, 20.4% already used Internet of Things technologies in 2023.[8]
  • Among healthcare and medical-device IoT respondents, 9% had deployed between 10,001 and 100,000 connected devices in 2023.[12]

05 Statistics

Data & Analytics

Data and analytics emphasizes quantified practice outcomes: 47% of surveyed contact-lens practices quantified impact in 2023 and 29% of sales were conducted online in 2025.

Business intelligence in the contact lens industry

  • 47% of surveyed contact-lens practices quantified the business impact of contact-lens patients versus non-wearing patients in 2023.[13]
  • 600 contact-lens patients at 20 U.S. optometry practices were included in the Contact Lens Institute’s profitability analysis.[13]
  • 94% of surveyed practices perceived a positive contact-lens culture in 2023.[13]
  • 50.4% of respondents to the 2024 U.S. Contact Lens Report worked in private practice.[14]
  • 16 of 21 contact-lens practice factors scored above 70% importance in the Contact Lens Institute’s 2023 research.[13]
  • 248 U.S. optometrists responded to the 2024 Contact Lens Report survey used for contact-lens practice analysis.[14]

Data analytics in the contact lens industry

  • 4.1% was the tracking growth rate for global contact-lens sales value in 2025 according to NIQ global optics sales reporting.[15]
  • 5.5% was the growth in global contact-lens sales value in 2024 according to NIQ global optics sales reporting.[15]
  • 29% was the global share of contact-lens sales conducted online according to NIQ’s 2025 optics reporting.[15]
  • 47% of contact-lens practices quantified the financial impact of contact-lens versus non-wearing patients in 2023.[13]
  • 7% was the year-on-year increase in global online contact-lens sales reported by NIQ for 2025.[15]
  • 21 practice factors were evaluated for their importance in improving contact-lens culture in the 2023 Contact Lens Institute research.[13]

Data Quality in the medical devices sector (sector benchmark)

  • 56% of medical-device companies used non-validated general-purpose tools for clinical data collection in the 2024 MedTech industry survey.[16]
  • 73% of medical-device professionals using literature-review software trusted their data quality, compared with 38% using spreadsheets, in a global survey; survey year not stated.[17]
  • 51% of medical-device companies still managed postmarket-surveillance processes and data manually or partially manually in the 2025 benchmark survey.[7]
  • 45.9% of healthcare-sector business partners identified data quality as a major challenge in managing digital product information in the 2021 survey.[18]
  • 60% of medical-device professionals using literature-review software reported data traceability, compared with 4% using spreadsheets, in a global survey; survey year not stated.[17]

Data Governance in the medical devices sector (sector benchmark)

  • 31.4% of healthcare-sector business partners had a digital-asset-management system for storing images and product data sheets in the 2021 survey.[18]
  • More than 72% of healthcare-sector business partners had not established a product-master-data system reflecting data governance in the 2021 survey.[18]
  • 62.3% of healthcare-sector business partners identified creating a central data master as a single source of truth as the greatest digital-product-information challenge in 2021.[18]
  • More than 30% of healthcare-sector business partners had no clear formal data-governance guidelines in the 2021 survey.[18]

KPIs in the contact lens industry

  • 80% of new U.S. contact-lens wearers rated full listening to their concerns as likely to influence continued wear in 2024.[13]
  • 74.6% of U.S. optometrists surveyed in 2024 selected daily disposables as their go-to initial modality for first-time contact-lens wearers.[14]
  • 77% of new U.S. contact-lens wearers rated post-appointment follow-up as likely to influence continued wear in 2024.[13]
  • 22% of contact-lens wearers were estimated to discontinue lens wear at some point according to the literature review cited in the 2024 Contact Lens Report.[14]
  • 84% of long-term U.S. contact-lens wearers rated full listening to their concerns as likely to influence continued wear in 2024.[13]
  • $24,000 was the estimated maximum lifetime revenue loss per patient associated with contact-lens dropout in the 2024 Contact Lens Report.[14]

06 Statistics

Strategy & Growth

Strategy and growth sections tie product mix to results, including CooperVision fiscal-2025 sales at $2.7438 million and MiSight 1 day’s FDA indication to slow childhood myopia progression ages 8–12.

Growth in the contact lens industry

  • CooperVision’s fiscal-2023 revenue reached $2,609.4 million, up 8% year over year and 9% organically.[19]
  • CooperVision’s fiscal-2025 net sales increased 5% to $2,743.8 million.[20]
  • CooperVision’s sphere-and-other sales increased 3% to $1,392.5 million in fiscal 2025.[20]
  • Johnson & Johnson’s worldwide Contact Lenses/Other sales increased 4.8% to $3,910 million in 2025.[19]
  • Alcon’s contact-lens net sales increased 6% to $2.8 billion in 2025.[19]
  • Johnson & Johnson’s international Contact Lenses/Other sales increased 5.3% to $2,157 million in 2025.[19]

Differentiation in the contact lens industry

  • 51% of CooperVision’s fiscal-2025 sales came from sphere and other lenses.[20]
  • 49% of CooperVision’s fiscal-2025 sales came from toric and multifocal lenses, compared with 48% in fiscal 2024.[20]
  • Alcon’s contact-lens portfolio in 2025 included daily disposable, reusable and color-enhancing lenses.[19]
  • CooperVision’s MiSight 1 day was described as the first and only FDA-approved lens indicated to slow childhood myopia progression for treatment initiated at ages 8–12.[19]
  • CooperVision expanded MyDay multifocal and toric parameters into new international markets during fiscal 2023.[19]

Mergers and acquisitions in the contact lens industry

  • $33.0 million was the purchase price for CooperVision’s November 2022 acquisition of SynergEyes, a specialty contact-lens company.[19]
  • Bausch + Lomb acquired the Blink OTC product line, including Blink Contacts lens drops, from Johnson & Johnson Vision in July 2023.[19]
  • CooperVision acquired Blueyes Ltd., a long-standing Israeli contact-lens distribution partner, on January 4, 2018.[19]
  • CooperVision acquired Paragon Vision Sciences, a specialty orthokeratology and rigid-lens business, on December 1, 2017.[19]
  • CooperVision completed its acquisition of SynergEyes, a provider of scleral and hybrid contact lenses, on November 1, 2022.[19]
  • CooperVision acquired Grand Vista LLC, a Russian contact-lens distribution partner, on June 30, 2017.[19]

Strategic partnerships in the contact lens industry

  • Alcon’s MARLO practice platform announced a partnership with RevolutionEHR in 2025 to support electronic-health-record integration.[21]
  • CooperVision’s MiSight advocacy helped support myopia-management guideline adoption by two international professional associations in fiscal 2023.[19]
  • CooperVision’s Plastic Bank partnership covered participating lenses sold and distributed across 27 countries.[22]
  • CooperVision renewed its net-plastic-neutrality partnership with Plastic Bank through 2026.[22]

07 Statistics

People & Workforce

People and workforce data shows scale and staffing mix, including 13,500 Bausch + Lomb employees globally at December 31, 2024 with 7,200 in production.

Hiring in the contact lens industry

  • 957 employees worked at STAAR Surgical as of January 2, 2026, including 406 outside the United States.[19]
  • 4,300 Bausch + Lomb employees worked in the company’s global commercial team in 2024, supporting products including contact lenses.[19]
  • 1,150 Bausch + Lomb U.S. commercial employees supported contact-lens, lens-care, consumer eye-health, surgical and pharmaceutical products in 2024.[19]
  • 13,500 employees worked at Bausch + Lomb globally at December 31, 2024, including 7,200 in production, 4,300 in sales and marketing, 1,000 in general and administrative roles, and 1,000 in R&D.[19]

Employee retention in the contact lens industry

  • 36 temporary employees worked at STAAR Surgical as of January 2, 2026.[19]
  • 75% of employees surveyed by Bausch + Lomb in 2024 said the company’s health-care and wellness benefits met their needs.[19]
  • 921 regular full-time employees worked at STAAR Surgical as of January 2, 2026.[19]
  • 32.2% was STAAR Surgical’s global employee turnover rate in fiscal 2025, excluding temporary employees.[19]

Remote Work in the medical devices sector (sector benchmark)

  • Remote medical device and diagnostics professionals reported a median salary of $142,000 in 2023, according to an industry salary survey.[23]
  • Remote medical device and diagnostics employees worked an average of 41.5 hours per week in 2023, compared with 43 hours for office-based employees.[23]
  • Remote medical device and diagnostics professionals reported a median 4% pay increase in 2023, according to an industry salary survey.[23]
  • About 50% of medical device and diagnostics professionals worked fully remotely in 2023, based on 226 usable survey responses in the United States.[23]

Hybrid Work in the medical devices sector (sector benchmark)

  • Hybrid medical device and diagnostics professionals reported a median 4% pay increase in 2023, according to an industry salary survey.[23]
  • Hybrid medical device and diagnostics professionals represented about 40% of respondents in MD+DI’s 2023 salary survey, covering 226 usable responses.[23]
  • Hybrid medical device professionals reported a median salary of $150,000 in 2026, compared with $140,000 for remote and $116,000 for in-office professionals.[23]
  • Hybrid medical device and diagnostics professionals reported a median salary of $135,000 in 2023, according to an industry salary survey.[23]

Upskilling in the contact lens industry

  • 1,000 Bausch + Lomb employees worked in research and development in 2024, supporting product development including contact lenses.[19]
  • 1,000 Bausch + Lomb employees worked in general and administrative positions in 2024, within a 13,500-person global workforce.[19]
  • 2,000-plus CooperCompanies employees participated in employee resource groups in 2023, supporting inclusive professional networks and employee development.[22]
  • 50 EssilorLuxottica design and R&D facilities operated worldwide in 2024, supporting innovation across lens and eyewear businesses including contact lenses.[24]

Employee Engagement in the medical devices sector (sector benchmark)

  • In medical devices, 23% of employees disagreed that their total compensation was fair relative to similar roles at other companies in the 2026 benchmark.[25]
  • In medical devices, 91% of employees agreed they understood how their work contributed to company goals in benchmark data collected through June 2026.[25]
  • Medical devices organizations had a median employee net promoter score of 14 in Culture Amp’s 2026 benchmark.[25]
  • In medical devices, 73% of employees were engaged in benchmark data collected from July 2025 through June 2026, predominantly across Northern America, Oceania, Europe and Asia.[25]

DEI in the contact lens industry

  • 41.1% was women’s average pay as a percentage of men’s average pay across HOYA employees in Japan in FY2025; the company attributed the gap partly to its contact-lens retail workforce.[26]
  • 37.5% of HOYA’s directors and executive officers, including executive officers, were women in FY2025.[26]
  • Almost 50% of EssilorLuxottica employees were under 35 in 2024.[24]
  • 60% of EssilorLuxottica’s more than 205,000 employees were women in 2024.[24]
  • 28.6% of HOYA’s seven directors were female in FY2025.[26]

Change Management in the medical devices sector (sector benchmark)

  • Among post-market medical device companies surveyed in 2023, 37% cited resistance to change efforts as a challenge to improving quality management processes.[16]

08 Statistics

Customer & Sales

Customer and sales inputs highlight channel behavior with 65% of U.S. purchases made in person in 2025 and daily disposables dominating first-time modality at 74.6% for U.S. optometrists.

Customer experience in the contact lens industry

  • 65% of U.S. contact-lens purchases were made in person in 2025, while in-person purchases recorded a Net Promoter Score of 56.[27]
  • 46% of U.S. new contact-lens wearers cited freedom from glasses among their top satisfaction reasons in 2024, compared with 61% of long-term wearers.[13]
  • 46% of U.S. new contact-lens wearers cited convenience among their top satisfaction reasons in 2024, compared with 51% of long-term wearers.[13]
  • 51% of U.S. new contact-lens wearers cited vision among their top satisfaction reasons in 2024, compared with 67% of long-term wearers.[13]
  • 67% of U.S. new contact-lens wearers were highly satisfied in 2024, compared with 86% of long-term wearers.[13]

Customer retention in the contact lens industry

  • Eyecare Club members receive two eye exams annually and 10% off contact lenses and eyeglasses during their three-year membership as of 2026.[28]
  • 87% of U.S. long-term contact-lens wearers had never stopped wearing lenses in 2024.[13]
  • 1.3 million customers were active Eyecare Club members at America’s Best as of January 3, 2026; the program primarily serves contact-lens customers.[28]
  • 26% of contact-lens wearers abandoned lens use within their first year, according to research cited by the Contact Lens Institute in 2024.[13]
  • 9% of U.S. long-term contact-lens wearers had paused lens use more than two years earlier in 2024.[13]

Customer acquisition in the contact lens industry

  • 241 million parents were the target audience for CooperVision’s MiSight 1 day launch campaign in 2020.[29]
  • 875 million impressions were generated by CooperVision’s MiSight 1 day campaign in 2020, exceeding its awareness goal by more than 360%.[29]
  • 861 million parents were reached by CooperVision’s MiSight 1 day campaign in 2020, exceeding its reach goal by 456%.[29]
  • 33.2 million parents took direct action on social and digital channels during CooperVision’s MiSight 1 day campaign in 2020.[29]
  • 12.9 million parents were targeted for action through social and digital tactics in CooperVision’s MiSight 1 day campaign in 2020.[29]

Customer loyalty in the contact lens industry

  • 77% of U.S. Gen X contact-lens wearers said remaining with their current eye-care professional was very or extremely important in 2025.[13]
  • 87% of U.S. Millennial contact-lens wearers said they would probably or definitely continue purchasing their current contact-lens brands in 2025.[13]
  • 68% of U.S. Millennial contact-lens wearers said remaining with their current eye-care professional was very or extremely important in 2025.[13]
  • 86% of U.S. Gen Z contact-lens wearers said they would probably or definitely continue purchasing their current contact-lens brands in 2025.[13]
  • 67% of U.S. Gen Z contact-lens wearers said remaining with their current eye-care professional was very or extremely important in 2025.[13]

09 Statistics

Marketing & Brand

Marketing and brand evidence includes distribution reach and social performance, such as 875 million impressions for CooperVision’s MiSight 1 day campaign in 2020.

Marketing in the contact lens industry

  • 609.3 million parent impressions included a call to action in CooperVision’s MiSight 1 day campaign in 2020.[29]
  • 875 million impressions were generated by CooperVision’s 2020 MiSight 1 day launch campaign across media, influencers, and digital channels.[29]
  • 4,000 qualified eye-care practitioners were part of CooperVision’s MiSight 1 day practitioner-finder acquisition pathway in 2020.[29]
  • 30 U.S. markets were reached by a one-day satellite media tour supporting CooperVision’s MiSight 1 day campaign in 2020.[29]

Digital marketing in the contact lens industry

  • 1.2 million organic TikTok views were generated by Acuvue-owned content featuring the Acuvue twins by January 2026.[30]
  • 84,000 likes were generated by Acuvue-owned TikTok content featuring the Acuvue twins by January 2026.[30]
  • 17,800 shares or reposts were generated by Acuvue creator and owned content by January 2026.[30]
  • 2,000 comments were generated by Acuvue-owned TikTok content featuring the Acuvue twins by January 2026.[30]
  • 1 million TikTok views were reached within days by Johnson & Johnson Vision Care’s Acuvue Max Astigmatism influencer launch in 2026.[30]

Branding in the contact lens industry

  • 79% of U.S. Gen Z contact-lens wearers said current eye-care product brands work best for them in 2025.[13]
  • 80% of U.S. Gen X contact-lens wearers said current eye-care product brands work best for them in 2025.[13]
  • 65% of U.S. consumers said eye doctors influenced their contact-lens purchase in 2023.[13]
  • 81% of U.S. Gen Z contact-lens wearers cited cost or value as a reason to continue purchasing current eye-care product brands in 2025.[13]
  • 78% of U.S. Millennials cited cost or value as a reason to continue purchasing current eye-care product brands in 2025.[13]

Influencer Marketing in the medical devices sector (sector benchmark)

  • 8.57 million influencer posts about the health industry were published globally in 2023, across the platforms measured by Sprout Social.[31]
  • 29% of healthcare and pharmaceutical marketers had dedicated but flat budgets for creator or influencer marketing in 2026.[32]
  • 50% of healthcare and pharmaceutical marketers had dedicated, growing budgets for creator or influencer marketing in 2026.[32]
  • 10% of healthcare and pharmaceutical marketers reported that they did not invest in creator or influencer marketing in 2026.[32]
  • 1.07% was the average engagement rate for health-industry influencer posts globally in 2023, across the platforms measured by Sprout Social.[31]

10 Statistics

Operations & Execution

Operations and execution measures quality and manufacturing capacity, including a 0.035% global recall rate in 2024 and Alcon planning three additional production lines for Grosswallstadt.

Process optimization in the contact lens industry

  • 3 additional contact-lens production lines were planned for Alcon’s Grosswallstadt, Germany, expansion project, with anticipated investment of $162 million.[19]
  • 7% was Alcon Vision Care’s reported revenue growth in 2025, reflecting operational execution across its eye-care portfolio.[19]
  • $162 million was the anticipated cost of Alcon’s Grosswallstadt contact-lens facility expansion in Germany.[19]
  • 90% of Alcon’s products were manufactured internally in 2025, supporting tighter control over production processes.[19]
  • 100% of Alcon’s manufacturing plants were certified to ISO 13485:2016 and ISO 14001:2015 in 2025.[19]

Operational efficiency in the contact lens industry

  • 67% was CooperVision’s fiscal-2024 gross margin.[19]
  • $729.6 million was CooperVision’s operating income in fiscal 2025.[19]
  • 18% was CooperCompanies’ fiscal-2024 operating margin, up from 15% in fiscal 2023.[19]
  • 7 facilities produced Alcon Vision Care products in 2025 across 4 countries.[19]
  • 90% of Alcon’s products were manufactured internally in 2025, limiting reliance on external production capacity.[19]

Quality management in the contact lens industry

  • 100% of Alcon manufacturing plants were ISO 14001:2015 certified in 2025.[19]
  • 92,835 packs of DAILIES TOTAL1 and TOTAL30 contact lenses were listed in an Alcon U.S. and international recall in 2024.[33]
  • 2,842 contact lenses were listed in the 24K Premium recall in the United States in 2024.[33]
  • 1 manufacturing-site material issue triggered the 2024 Alcon DAILIES TOTAL1 and TOTAL30 recall.[33]
  • 0.035% was Alcon Vision Care’s global recall rate in 2024.[34]

Supply chain in the contact lens industry

  • 3 contact-lens production lines were planned for Alcon’s Grosswallstadt, Germany, expansion project.[19]
  • 1 third-party vendor’s material was identified as the source of an isolated quality issue affecting specific Alcon contact-lens lots in 2024.[35]
  • $162 million was the anticipated investment in Alcon’s Grosswallstadt contact-lens expansion.[19]
  • 7 Alcon Vision Care manufacturing facilities operated across the United States, Germany, Singapore and Malaysia in 2025.[19]
  • 4 countries hosted Alcon Vision Care manufacturing facilities in 2025.[19]

Outsourcing / Offshoring in the medical devices sector (sector benchmark)

  • 11.4% was the year-over-year growth rate of the global medtech outsourcing market in 2023.[36]
  • 335 U.S. medical device contract manufacturers were identified in 2022, up from 314 in the prior registry.[36]
  • More than half of 59 global medtech CDMO transactions in 2023 had cross-border characteristics.[36]
  • $81.5 billion was the global medtech outsourcing market in 2023, covering contract development and manufacturing organizations (CDMOs).[36]
  • $26.3 billion was the U.S. medtech CDMO market in 2023, after 12.9% growth from 2022.[36]

11 Statistics

Finance & Pricing

Finance and pricing coverage includes premium levels and cash flow signals, including an estimated 20%–40% pricing premium for toric and multifocal lenses over spherical in 2024.

Pricing strategy in the contact lens industry

  • 10% was Alcon’s reported contact-lens sales growth in the fourth quarter of 2024.[19]
  • Approximately 8 percentage points per year was the reported increase in U.S. daily silicone-hydrogel penetration in recent Baird surveys through 2024.[37]
  • 20%–40% was the approximate pricing premium for Alcon toric and multifocal lenses over spherical lenses in 2024.[19]
  • 11% was Alcon’s fourth-quarter 2024 constant-currency contact-lens sales growth after currency effects.[19]
  • $51 million was Bausch + Lomb’s 2025 net-pricing contribution to Vision Care revenue growth.[19]

Cost reduction in the contact lens industry

  • $288.1 million was CooperCompanies’ fiscal-2024 free cash flow after operating cash generation and capital expenditure.[19]
  • $969.3 million was CooperVision’s selling, general and administrative expense in fiscal 2025.[19]
  • $91.3 million was CooperVision’s research-and-development expense in fiscal 2025.[19]
  • $21.0 million was CooperVision’s amortization expense in fiscal 2025.[19]
  • $421.2 million was CooperCompanies’ capital expenditure in fiscal 2024.[19]

Profitability in the contact lens industry

  • $360 million was Bausch + Lomb’s net loss attributable to the company in 2025.[19]
  • 18% was CooperCompanies’ fiscal-2024 operating margin.[19]
  • $2,923 million was Bausch + Lomb’s reported Vision Care revenue in 2025.[19]
  • $2,890 million was Bausch + Lomb’s 2025 constant-currency Vision Care revenue.[19]
  • 26.6% was CooperVision’s approximate fiscal-2025 operating margin calculated from $729.6 million of operating income and $2,743.8 million of sales.[19]

Financial planning in the contact lens industry

  • 3 additional production lines were planned in Alcon’s Grosswallstadt contact-lens expansion project.[19]
  • $709.3 million was CooperCompanies’ cash provided by operations in fiscal 2024.[19]
  • $2,743.8 million was CooperVision’s fiscal-2025 sales base against which operating resources were planned.[19]
  • $162 million was Alcon’s anticipated investment in the Grosswallstadt, Germany, contact-lens expansion project.[19]
  • $288.1 million was CooperCompanies’ fiscal-2024 free cash flow.[19]

12 Statistics

Product & Service

Product and service inputs track modality and material mix, including 60% one-day lens ratio in FY2024 and 78% silicone-hydrogel share in the 2025 international prescribing survey.

Product development in the contact lens industry

  • More than 2,100 people worked in Alcon’s research-and-development organization in 2025, including physicians, optometrists and PhDs.[19]
  • $990 million was invested in research and development by Alcon in 2025 globally, supporting ophthalmic and contact-lens product development.[19]
  • Alcon launched the weekly PRECISION7 contact lens in 2024.[19]
  • More than 84 pipeline projects were in Alcon’s Surgical and Vision Care pipelines at December 31, 2025.[19]
  • More than 70 Alcon pipeline products were under development in 2024 globally.[34]

Product lifecycle in the contact lens industry

  • 63% of global contact-lens monthly-equivalent units were reusable lenses in 2024, compared with 68% in 2020.[34]
  • 12% of global contact-lens retail value came from multifocal lenses in 2024, compared with 11% in 2020.[34]
  • 56% of contact-lens wearers in 34 EMEA countries used daily disposables in 2024.[38]
  • 61% of rigid contact lenses were prescribed on a planned-replacement basis in the 2025 international prescribing survey.[39]
  • 78% of soft contact-lens fits in the 2025 international prescribing survey used silicone-hydrogel materials.[39]

After-sales in the contact lens industry

  • 80% of new U.S. contact-lens wearers said fully listening to their concerns would influence continued wear in 2024.[13]
  • 79% of new U.S. contact-lens wearers said quickly scheduling an appointment would influence continued wear in 2024.[13]
  • 62% of long-term U.S. contact-lens wearers said post-appointment follow-up about vision or comfort would influence continued wear in 2024.[13]
  • 60% of U.S. and Canadian contact-lens patients were very satisfied with optician guidance on lens wear and care in 2026.[13]
  • 72% of new U.S. contact-lens wearers said being taught proper lens care would influence continued wear in 2024.[13]

Value proposition in the contact lens industry

  • Almost 80% of Gen X contact-lens wearers considered remaining with their existing doctor or practice very or extremely important in 2025.[13]
  • 67% of new U.S. soft contact-lens wearers reported overall satisfaction in the 2024 Contact Lens Institute study.[13]
  • 44% of U.S. glasses-only wearers expressed interest in contact lenses while saying their doctor or staff had never raised the option in 2023.[13]
  • 94% of surveyed U.S. practices believed they already had a positive contact-lens culture in 2023.[13]
  • 23% was the loyalty advantage among Gen X contact-lens wearers who considered remaining with their existing doctor or practice very or extremely important in 2025.[13]

13 Statistics

Sustainability & Ethics

Sustainability and ethics coverage includes collection outcomes, such as 114 million units of used contact lenses, eye-care and lens-care materials collected through Bausch + Lomb recycling programs by November 2025.

Sustainability in the contact lens industry

  • About 12% was the reduction in Bausch + Lomb’s total waste generated in 2025 compared with its 2022 baseline.[40]
  • Approximately 480,000 pounds of used contact lenses and eye-care and lens-care materials had been collected by Bausch + Lomb’s U.S. programs by December 2023.[40]
  • 360 million plastic-bottle equivalents had been prevented from entering oceans through CooperVision’s net-plastic-neutral contact-lens initiative by September 2024.[41]
  • 15% of former contact-lens wearers in a U.S. consumer survey said lack of sustainability was a factor in their decision to stop wearing lenses in 2021.[41]
  • 114 million units of used contact lenses, eye-care and lens-care materials had been collected through Bausch + Lomb recycling programs in the United States by November 2025.[40]

ESG in the contact lens industry

  • $990 million or more was Alcon’s research-and-development investment in 2025.[21]
  • More than 32,000 children received vision screenings through Alcon’s social-impact activities in 2025.[21]
  • More than 99% was Alcon’s waste-diversion rate at its manufacturing, technology and operations sites in 2025.[21]
  • More than 1.6 million people received vision-improvement support through Alcon Cares, the Alcon Foundation and related programs in 2025.[21]
  • 1,900 suppliers were screened by Bausch + Lomb for social and environmental risk in its supply chain in 2025.[40]

Ethics in the contact lens industry

  • 32.9% of U.S. adult contact-lens wearers recalled never hearing any lens-wear or lens-care recommendation from an eye-care provider in 2018.[42]
  • 19.8% of U.S. adult contact-lens wearers recalled being told not to top off contact-lens solution in 2018.[42]
  • 79% of U.S. eye-care providers reported recommending hand washing and drying always or most of the time during regular contact-lens visits in 2018.[42]
  • 85% of U.S. eye-care providers reported recommending compliance with lens-replacement schedules always or most of the time during regular visits in 2018.[42]
  • 79% of U.S. eye-care providers reported recommending that patients not sleep in lenses always or most of the time during regular visits in 2018.[42]

CSR in the contact lens industry

  • $10 was donated to Optometry Giving Sight by TerraCycle for every 10 pounds of materials collected through Bausch + Lomb’s recycling program.[43]
  • 569,743 pounds of used contact-lens, eye-care and lens-care materials had been collected by Bausch + Lomb’s U.S. recycling programs by November 2024.[44]
  • More than 32,000 children received vision screenings through Alcon’s social-impact programs in 2025.[21]
  • 690,000 pounds of used eye-health products had been collected through Bausch + Lomb’s ONE by ONE program by November 2025.[40]
  • 625,026 pounds of used contact-lens, eye-care and lens-care materials had been collected in the United States by Bausch + Lomb’s programs when the company reported the milestone.[45]

Circular economy in the contact lens industry

  • Approximately 9,305 grams of plastic waste was generated from contact lenses and blister packs by the surveyed group in one year.[46]
  • 16.7% was the reported recycling or reuse rate for contact-lens-related plastic waste among surveyed optometric-practice users.[46]
  • Approximately 48 kilograms of total plastic waste from lenses, blister packs, solution and cases was generated by surveyed respondents in one year.[46]
  • 0.04% of contact-lens-use waste was recycled in the United States in the study’s assessment of lens and packaging disposal.[47]

Carbon footprint in the contact lens industry

  • 1,647 kilograms of CO2e was attributed to contact lenses, contact-lens solution and spectacles combined in the annual NHS sight-test analysis for 2020.[48]
  • 93% is Bausch + Lomb’s target reduction in Scope 1 and Scope 2 emissions by 2050 under its net-zero commitment.[40]
  • 690 kilograms of CO2e was attributed to contact lenses in the annual carbon-footprint analysis of five NHS sight-test practices in the United Kingdom for 2020.[48]

15 Statistics

Globalization & Expansion

Globalization in the contact lens industry

  • $1,124.3 million of CooperVision’s fiscal-2025 sales came from the Americas.[20]
  • $1,064.4 million of CooperVision’s fiscal-2025 sales came from EMEA.[20]
  • $3.91 billion was Johnson & Johnson’s worldwide Contact Lenses/Other sales in 2025.[19]
  • 27 countries across the Americas, Europe and Asia-Pacific received participating CooperVision lenses covered by its plastic-neutrality program.[22]
  • $2.157 billion was Johnson & Johnson’s international Contact Lenses/Other sales in 2025.[19]

Cultural adaptation in the contact lens industry

  • MiSight 1 day received Chinese NMPA approval for use in China, extending CooperVision’s myopia-management offering into that market.[19]
  • More than 56% of users in earlier 2018 studies wore contact lenses for cosmetic reasons, according to a 2024 comparative study.[58]
  • 65% of international contact-lens fits in 2023 were to females, according to the annual international prescribing survey.[39]
  • Young female wearers were the dominant group in a 2025 Selangor contact-lens study, with preference reported for monthly and cosmetic lenses.[59]
  • 38% of international contact-lens fits in 2023 were new fits for people without recent contact-lens experience.[39]

Supplier management in the contact lens industry

  • $16.0 million of CooperVision’s fiscal-2025 category growth was positively affected by favorable foreign-exchange movements.[20]
  • National Vision transitioned contact-lens fulfillment and distribution from AC Lens to a third-party vendor in 2024.[19]
  • Contact-lens suppliers were described as concentrated among a few major vendors in the retailer’s 2025 annual report.[60]
  • One lens supplier was vertically integrated into the retailer’s supply chain, according to a 2025 contact-lens retail annual report.[60]

Stakeholder management in the contact lens industry

  • CooperVision’s orthokeratology products grew 24% in constant currency during fiscal 2023.[19]
  • CooperVision’s MiSight myopia-management business grew 49% in fiscal 2023, according to the company’s proxy disclosure.[19]
  • CooperVision’s participating soft contact lenses, blisters and packaging were covered by plastic collection and recycling equivalent to their material weight across 27 countries.[22]
  • CooperVision renewed its Plastic Bank net-plastic-neutrality partnership through 2026.[22]

Distribution channels in the contact lens industry

  • 22% of new U.S. contact-lens wearers used their eye doctor’s web page or app for purchases in 2024.[13]
  • 45% of long-term U.S. contact-lens wearers bought lenses through an eye-care practice in 2024.[13]
  • 15% of new U.S. contact-lens wearers bought from a retail store not affiliated with their eye doctor in 2024.[13]
  • 33% of U.S. consumers bought contact lenses online in the second quarter of 2024.[13]
  • 30% of new U.S. contact-lens wearers bought lenses at their eye doctor’s physical office in 2024.[13]

Key questions about the Contact Lens Industry

What is the current market size for contact lenses?
The global contact lens market was valued at $12.0 billion in 2025.
How fast is the contact lens market growing into 2033?
The market forecast CAGR for 2026–2033 is 3.9%, reaching $16.2 billion by 2033.
Which companies lead the contact lens industry?
HOYA leads Gitnux's 2026 contact lens ranking with an Overall score of 9.6, with revenue growth 9% and operating margin 30.1%. Johnson & Johnson is the runner-up at 9.4, with manufactures more than 1.7 billion ACUVUE lenses annually for U.S. patients.
Which technology shift is most visible in lens materials and fitting?
Silicone-hydrogel use reached 70% of global soft-contact-lens fittings in 2024, and 78% of soft contact-lens fits in the 2025 international prescribing survey used silicone-hydrogel.
How concentrated is the contact lens market among key players?
The market is concentrated among Johnson & Johnson Vision, Alcon, CooperVision, Bausch + Lomb, and Menicon.
What regulatory pathway applies in the United States for contact lenses?
Contact lenses are medical devices in the U.S. and require FDA review before marketing, with corrective and decorative lenses cleared 510(k) or approved PMA.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Elif Demirci. (2026, February 13). Contact Lens Industry Statistics. Gitnux. https://gitnux.org/contact-lens-industry-statistics
MLA
Elif Demirci. "Contact Lens Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/contact-lens-industry-statistics.
Chicago
Elif Demirci. 2026. "Contact Lens Industry Statistics." Gitnux. https://gitnux.org/contact-lens-industry-statistics.

Sources & references

73 sources cited across this report

  1. pubmed.ncbi.nlm.nih.gov
  2. discovery.ucl.ac.uk
  3. taiwan-healthcare.org
  4. nsf.org
  5. mastercontrol.com
  6. bcg.com
  7. veeva.com
  8. monitor-industrial-ecosystems.ec.europa.eu
  9. pages.awscloud.com
  10. modeln.com
  11. plm.automation.siemens.com
  12. eseye.com
  13. contactlensinstitute.org
  14. eyesoneyecare.com
  15. nielseniq.com
  16. blog.greenlight.guru
  17. distillersr.com
  18. sana-suisse-med.ch
  19. sec.gov
  20. investor.coopercos.com
  21. alcon.com
  22. coopercos.com
  23. mddionline.com
  24. media.essilorluxottica.com
  25. cultureamp.com
  26. hoya.com
  27. thevisioncouncil.org
  28. ir.nationalvision.com
  29. shortyawards.com
  30. optometricmanagement.com
  31. media.sproutsocial.com
  32. brand-news.it
  33. accessdata.fda.gov
  34. s1.q4cdn.com
  35. recalls-rappels.canada.ca
  36. alirahealth.com
  37. clspectrum.com
  38. euromcontact.org
  39. pv-cls-staging.hbrsd.com
  40. bausch.com
  41. coopervision.com
  42. cdc.gov
  43. financialfilings.com
  44. bausch.bl-ppd.com
  45. ir.bausch.com
  46. doi.org
  47. pubs.acs.org
  48. abdo.org.uk
  49. clao.org
  50. aao.org
  51. greenlight.guru
  52. cognition.us
  53. runsafesecurity.com
  54. dennemeyer.com
  55. mdic.org
  56. deloitte.com
  57. 2bridge.partners
  58. jclrs.org
  59. ijtmrph.org
  60. d18rn0p25nwr6d.cloudfront.net
  61. grandviewresearch.com
  62. 144246346.fs1.hubspotusercontent-eu1.net
  63. mordorintelligence.com
  64. alconannualreport.com
  65. fda.gov
  66. investor.alcon.com
  67. zeiss.com
  68. jnj.com
  69. seed.co.jp
  70. menicon.com
  71. euclidvisiongroup.com
  72. clearlab.com
  73. stshine.com.tw